← FDA Drug Approvals (Drugs@FDA)

CLARINEX

NDA · New Drug Application · Sponsor: SCHERING · Approved 2004-09-01

Drug application

FDA Application #

NDA021563

Application type

New Drug Application

Brand name

CLARINEX

Generic name

Desloratadine

Active ingredients

DESLORATADINE

Dosage form

SYRUP

Route

ORAL

Marketing status

Prescription

Sponsor

SCHERING

First approval

2004-09-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown